Shanghai Pharmaceuticals Holding Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
10,341.00
8,129.00
7,652.00
9,630.00
8,863.00
6,928.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-4,139.00
-4,592.00
-4,586.00
-5,288.00
-4,294.00
-1,999.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
7,252.00
7,778.00
6,866.00
6,539.00
7,006.00
8,402.00
Cash Flow from Investing Activities
-5,029.00
-1,147.00
-4,927.00
-15,602.00
-7,952.00
-2,828.00
Cash Flow from Financing Activities
-5,996.00
-1,882.00
1,344.00
14,190.00
1,682.00
-1,216.00
Net Cash Inflow / Outflow
-3,777.00
4,750.00
3,277.00
5,112.00
676.00
4,337.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-3.00
2.00
-6.00
-14.00
-60.00
-19.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Shanghai Pharmaceuticals Holding Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
10341.2897831282
1058.71822167372
9,283.00
876.77%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-4139.50413160743
312.000021393006
-4,451.00
-1426.76%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
7252.79416970547
2142.48459511845
5,110.00
238.52%
Cash Flow from Investing Activities
-5029.94196923388
-4784.53319050893
-245.00
-5.13%
Cash Flow from Financing Activities
-5996.7729980839
2415.20209549924
-8,411.00
-348.29%
Net Cash Inflow / Outflow
-3777.29973769344
-259.127338021836
-3,518.00
-1357.70%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-3.37894008113331
-32.2808381305976
29.00
89.53%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -6.76% vs 13.28% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
7,252.79
7,778.45
-6.76%






